Neuroprotective effects of thymoquinone against cerebellar histopathological changes in propylthiouracilinduced hypothyroidism in adult rats
Purpose: To evaluate the effects of thymoquinone (TQ) on histological and immunohistochemical changes in the cerebellar cortex induced by propylthiouracil (PTU) treatment in rats.
Methods: Thirty-two adult male albino rats were randomly divided into four groups: C, control; PTU, treatment with oral PTU to induce hypothyroidism; TQ, treatment with TQ; and PTU + TQ, concomitant treatment with oral PTU and TQ for 6 weeks. Cavalieri’s principle and physical dissector methods were employed for unbiased deduction of cerebellar granular layer volume, numerical density, and number of granular cells.
Results: In the PTU group, hematoxylin and eosin (H&E)-stained sections revealed degeneration of Purkinje cells, neuronal loss, and spongiosis in the white matter. A decrease in the number of astrocytes-expressing glial fibrillary acidic protein (GFAP) and a significant decrease in granular layer cell density were also seen. Concomitant administration of TQ ameliorated histopathological changes, increased the proportion of GFAP-positive astrocytes, increased granular cell density, and significantly (p < 0.05) increased the levels of thyroid-stimulating hormones, T3 and T4.
Conclusion: TQ treatment significantly decreases cerebellar changes resulting from PTU-induced hypothyroidism, and results in the retention of neuronal structural integrity in the cerebellar cortex.
Keywords: Hypothyroidism, Cerebellum, Thymoquinone, Stereology, Glial fibrillary acidic protein, Neuronal structural integrity
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.